Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL.
暂无分享,去创建一个
J. Bedke | P. Goebell | T. Steiner | M. Schostak | M. Welslau | C. Grüllich | M. Boegemann | C. Doehn | J. Schleicher | R. Ehness | A. Petzold | Thomas Wolf | T. Medinger | D. Klein | C. Hering-Schubert | Viktor Grünwald